台股 » 個股 » 華上 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

華上

(6289)
  • 股價
    1.35
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    0
  • 產業
    上市 發光二極體(LED)▼0.34%
  • 27人加入追蹤

    立即追蹤

  • 本地時間:14:35

     
華上 (6289)籌碼相關-元大-高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2022/09/02201.0300.001.03202248.90%
2022/09/0100.0010.820.94-1206-0.49%
2022/08/3100.00130.810.86-13160-8.09%
2022/08/23101.2900.001.29107413.50%
2022/08/22151.4300.001.43157420.11%
2022/08/1711.9400.001.941711.40%
2022/07/2500.0022.522.52-250-3.99%
2022/07/0612.6000.002.541492.01%
2022/06/1312.8700.002.751621.61%
2022/04/111.43.0900.003.071.42020.69%
2022/02/1703.4800.003.1801980.00%
2022/02/0900.0013.253.25-1191-0.52%
2022/01/2423.3200.003.4621861.07%
2022/01/1443.4300.003.4441722.32%
2022/01/1153.6900.003.4751573.18%
2022/01/1000.0023.803.85-2147-1.35%
2021/11/0222.6900.002.652395.10%
2021/10/2500.000.22.622.58-0.239-0.57%
2021/09/1300.0002.682.75074-0.01%
2021/09/0300.000.12.882.87-0.172-0.11%
2021/06/2500.0012.922.92-188-1.13%
2021/04/2300.00203.703.79-20102-19.53%
2021/04/1600.00303.713.66-3091-32.76%
2021/02/2203.0500.003.250870.01%
2021/01/0700.000.63.994.07-0.6119-0.50%
2021/01/0500.0043.363.37-4117-3.42%
2020/12/2213.8700.003.8511690.59%
2020/11/2500.0033.463.46-3344-0.87%
2020/11/1000.000.73.513.66-0.7352-0.19%
2020/10/30954.0700.004.069534527.47%
2020/10/2600.0033.443.60-3345-0.87%
2020/10/1600.0034.844.54-3342-0.88%
2020/09/2337.1147.117.11-1272-0.37%
2020/09/2200.00306.456.47-30262-11.41%
2020/09/2100.003.65.895.89-3.6245-1.47%
2020/09/17104.8800.004.88102164.62%
2020/09/160.44.3500.004.440.42010.20%
2020/09/14204.4800.004.482015912.51%
2020/09/1114.0814.084.0801500.00%
2020/09/09503.3800.003.385012440.04%
2020/03/260.41.4500.001.550.41890.21%
2020/03/1000.00842.302.30-84274-30.55%
2020/03/0922.5500.002.5522790.72%
2020/02/1900.00220.800.80-22291-7.55%
2020/02/1750.8000.000.8052921.71%
2020/02/1400.00220.830.83-22287-7.64%
2020/02/1170.9000.000.9072852.45%
2020/01/2000.00200.870.87-20277-7.21%
2020/01/1050.8000.000.7752651.88%
2019/12/2530.8500.000.8532571.17%
2019/12/1151.1900.001.0552282.19%
2019/12/09501.0000.001.005021123.64%
2019/11/2570.8500.000.8771444.84%
2019/08/2250.5800.000.5851044.81%
2019/05/3100.00430.620.65-43211-20.36%
2019/05/2100.00500.600.62-50221-22.55%
2019/04/0950.6700.000.7052092.39%
2019/04/03100.8000.000.75101865.36%
2019/04/0120.9600.000.9121461.36%
2019/01/2100.00101.101.11-1092-10.78%
2018/09/2800.0001.661.5102170.00%
2018/07/26101.93251.951.61-15163-9.16%
2018/07/1821.3600.001.3621111.80%
2018/05/1431.7000.001.7031152.60%
2018/05/08251.6831.801.842210920.14%
2018/04/03101.9200.001.95101099.13%
2018/03/3132.0700.002.073953.15%
2018/03/2900.00242.062.07-2497-24.66%
2018/03/2700.000.12.112.13-0.197-0.09%
2018/03/15102.0300.002.06109710.29%
2018/03/05102.14102.142.1401200.00%
2018/03/01102.1500.002.20101267.93%
2018/02/26202.2300.002.282012615.85%
2018/01/3000.002.52.372.35-2.5133-1.87%
乳癌新藥剋必達上市 華上生醫IPO時程加速Anue鉅亨-2023/09/12
〈華上生醫展望〉乳癌新成分新藥拓展新適應症 肝癌試驗拚年底完成Anue鉅亨-2023/09/08
華上 相關文章